Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT01346605
Eligibility Criteria:
Inclusion Criteria:
* Moderate-high likelihood of coronary artery disease with a prior stress SPECTMPI exam likely to be referred to the cardiac catheterization laboratory for invasive angiogram or patients presenting with clinical indication of Coronary -CT Angiography and an initial calcium score above 300
* Stable angina or anginal equivalent as the chief symptom.
* Age \> 34 years old
* Able to comprehend and sign the consent form.
Exclusion Criteria:
* BMI\<41
* Acute coronary syndromes (unstable angina, non-ST elevation myocardial infarction, ST elevation myocardial infarction)
* Unstable clinical conditions (i.e. hemodynamic instability, arrhythmias)
* Premenopausal women who have menstruated in the last year
* Glomerular Filtration Rate (GFR) \< 60 ml/min/BSA as an indicator of renal insufficiency
* Known allergy to iodinated contrast agents
* Patients who are on metformin medication for any reason
* Atrial fibrillation
* Asthma
* Critical aortic stenosis
* Systolic blood pressure \< 90 mmHg
* Advanced heart block
* Pacemaker or AICD
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Years
Maximum Age:
80 Years
Study:
NCT01346605
Study Brief:
Protocol Section:
NCT01346605